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AN ANALYSIS OF A MATHEMATICAL MODEL DESCRIBING
THE GROWTH OF A TUMOR TREATED WITH
CHEMOTHERAPY
ANDERSON L. A. DE ARAUJO, ARTUR C. FASSONI, AND LUI´S F. SALVINO
Abstract. We present a mathematical analysis of a mixed ODE-PDE model
describing the spatial distribution and temporal evolution of tumor and nor-
mal cells within a tissue subject to the effects of a chemotherapeutic drug.
The model assumes that the influx of chemotherapy is restricted to a limited
region of the tissue, mimicking a blood vessel passing transversely. We provide
results on the existence and uniqueness of the model solution and numerical
simulations illustrating different model behaviors.
1. Introduction
The main objective of this work is to perform a rigorous mathematical analysis of
a system of nonlinear partial differential equations corresponding to a generalization
of a mathematical model describing the growth of a tumor proposed in [6].
To describe the model, let Ω ⊂ IR2, be an open and bounded set; let also 0 <
T < ∞ be a given final time of interest and denote t the times between [0, T ]
and Q = Ω × (0, T ), the space-time cylinder and Γ¯ = ∂Ω × (0, T ), the space-time
boundary. Then, the system of equations we are considering is the following:
(1.1)

∂N
∂t
= rN − µNN − β1NA− αNγNDN, in Q,
∂A
∂t
= rAA
(
1− A
kA
)
− (µA + A)A− αAγADA, in Q,
∂D
∂t
= σ∆D + µχω − γADA− γNDN − τD, in Q,
∂D
∂η
= 0, on Γ,
N(·, 0) = N0(·), A(·, 0) = A0(·), D(·, 0) = D0(·), in Ω.
In [6], Fassoni studied an ODE system corresponding to system (1.1) in a spa-
tially homogeneous setting. Such model describes the growth of a tumor and its
effect on the normal tissue, the tissue response to the tumor and the application
of chemotherapeutic treatments, without spatial heterogeneity. The aim of the
authors was to understand the phenomena of cancer onset and treatment as tran-
sitions between different basins of attraction of the underlying ODE system. The
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equations of the model that were studied in [6] are
(1.2)

dN
dt
= rN − µNN − β1NA− αNγNDN,
dA
dt
= rAA
(
1− A
kA
)
− (µA + A)A− β3NA− αAγADA,
dD
dt
= µ− γADA− γNDN − τD,
where N represents the number of normal cells in a given tissue of the human
body, A represents the number of tumor cells in the tissue and D represents the
concentration of a chemotherapeutic drug used to treat such a tumor.
Parameter rN represents a constant influx of new normal cells produced by the
tissue stem cells and µN presents the natural mortality of normal cells. A constant
influx is considered because the imperative dynamics within a formed tissue is the
maintenance of a homeostatic state through the natural replenishment of old and
dead cells, see [14].
On the other hand, tumor cells maintain their own growth program [7]. Thus,
a density dependent growth is considered for tumor cells. The logistic growth is
chosen due to its simplicity. Parameter µA represents the natural mortality of
tumor cells, and A represents an extra mortality rate due to apoptosis [4].
Parameters β1 and β3 encompass the many negative interactions exerted by
tumor cells on normal cells and vice-versa, such as competition for nutrients and
oxygen. Besides competition, parameter β3 encompasses also the effects on normal
cells of anti-growth and death signals released by normal cells. In the same way, the
parameter β1 encompasses also mechanisms developed by tumor cells that damage
normal tissue, such as increased local acidity, growth suppression, and release of
death signals [9].
The third equation of (1.2) describes the dynamics of chemotherapeutic drug
concentration according the following assumptions. The drug has a constant infu-
sion rate µ and a clearance rate τ . Such constant infusion rate mimics a metronomic
dosage, i.e., a near continuous and long-term administration of the drug. The ab-
sorption and deactivation of the drug by normal and cancerous cells are described
in terms of the law of mass action with rates γN and γA. Following the log-linear
hypothesis [3], it is assumed that the amounts of drug absorbed by normal (γNND)
and cancerous cells (γAAD) kill such cells with rates αN and αA, respectively. Al-
though many models of cancer treatment do not consider drug absorption explicitly,
in [6], the authors believe that it is an important fact to be considered, since, this
phenomenon contributes to decrease the concentration of drug as time passes.
System (1.2) is similar to the classical Lotka-Volterra competition model, fre-
quently used in models for tumor growth and population dynamics. The funda-
mental difference here is the use of a constant flux for normal cells instead of a
logistic growth. Such constant flux, also used in other well-known models of cancer
[5], removes the symmetry observed in the Lotka-Volterra equations, so that there is
no steady state with N = 0. Thus, it is impossible to observe the extinction of one
of the populations (the normal cells in this case), as opposed to the Lotka-Volterra
models. The authors of [6] claim that this is a realistic result since, roughly speak-
ing, cancer ”does not win” by killing all the cells in the tissue, but by reaching a
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dangerous size that disrupts the proper functioning of the tissue and threatens the
health of the individual.
In this work, we are not interested in analyzing the dynamics (stability, as-
ymptotic behavior) of the model, as such study has already been made in [6].
Our objective is to study the existence and uniqueness of the solution of system
(1.1). Such system extends the ODE model (1.2) to a more realistic situation by
considering spatial variation of normal and cancer cells and the diffusion of the
chemotherapeutic drug through the tissue, with diffusion coefficient σ [2]. Further,
it is also assumed that the drug influx is restricted to a limited region of the tis-
sue, corresponding to a blood vessel passing transversely in such region. This is
mathematically described in the model by the expression µχω, where χω is the
characteristic function of the subset ω ⊂ Ω. Finally, due to mathematical necessity
to simplify the model, we set β3 = 0. This corresponds to a situation where nor-
mal cells do not exert negative effects on tumor cells, and is a plausible biological
assumption, since there are many tumors that develop resistance to the normal
tissue’ mechanisms which suppress tumor growth [9].
The paper is organized as follows. In Section 2 we present the technical hypothe-
sis and state our main result. In Section 3 we study an auxiliary problem. Using its
solution, we prove our main result in Section 4. In Section 5 we present numerical
simulations illustrating model behavior.
2. Technical hypotheses and main result
Let Ω ⊂ IR2 be a domain with boundary ∂Ω, 0 ≤ T < ∞, and denote Q =
Ω× (0, T ) and Γ = ∂Ω× (0, T ). We will use standard notations for Sobolev spaces,
i.e., given 1 ≤ p ≤ +∞ and k ∈ N, we denote
W kp (Ω) = {f ∈ Lp(Ω) : Dαf ∈ Lp(Ω), |α| ≤ k} ;
when p = 2, as usual we denote W k2 (Ω) = H
k(Ω); properties of these spaces can be
found for instance in Adams [1, Theorem 5.4, p. 97]. Problem (1.1) will be studied
in the standard functional spaces denoted by
W 2,1q (Q) = {f ∈ Lq(Q) : Dαf ∈ Lq(Q), ∀1 ≤ |α| ≤ 2, ft ∈ Lq(Q)} ,
W = {f ∈ L∞(Q) : ft ∈ L∞(Q)}
and
Lp(0, T ;B) =
{
f : (0, T )→ B : ‖f(t)‖Lp(0,T ;B) < +∞
}
,
where B is suitable Banach space, and the norm is given by ‖f(t)‖Lp(0,T ;B) =
‖ ‖f(t)‖B ‖Lp((0,T )). We remark that Lp(Q) = Lp((0, T );Lp(Ω)). Results concern-
ing these spaces can be found for instance in Ladyzhenskaya [10] and Mikhaylov [15].
Next, we state some hypotheses that will be assumed throughout this article.
2.1. Technical Hypotheses:
(i) Ω ⊂ R2 is a bounded C2-domain;
(ii) 0 < T <∞, and Q = Ω× (0, T );
(iii) N0, A0 ∈ L∞(Ω) and D0 ∈W
3
2
4 (Ω), satisfying
∂D0
∂η (·) = 0, on ∂Ω;
(iv) 0 ≤ D0 ≤ µτ and N0, A0 ≥ 0 a.e. on Ω.
Remark 2.1. The constraints imposed in (iv) on the initial conditions are natural
biological requirements.
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2.2. Main result:
Theorem 2.2. Assume that the Technical Hypotheses 2.1 hold; then, there exists
a unique nonnegative solution (N,A,D) ∈ W ×W ×W 2,14 (Q) of Problem (1.1).
Moreover, N,A and D are functions satisfying
N ≤ ||N0||L∞(Q) + rNT, A ≤ Cλ||A0||L∞(Ω) a.e. in Q
and
||N ||W + ||A||W + ||D||W 2,14 (Q) ≤ C,
where C is a constant depending on rN , µN , β1, αN , γN , Cλ, rA, kA, µA, A, αA,
γA, µ, τ , T , ω, ||N0||L∞(Ω), ||A0||L∞(Ω) and ||D0||
W
3
2
4 (Ω)
.
Remark 2.3. The explicit knowledge on how the constant C appearing in the above
estimates depends on the given data is important for applications in related control
problems.
2.3. Known technical results: To ease the references, we also state some tech-
nical results to be used in this paper. The first one is sometimes called the Lions-
Peetre embedding theorem (see Lions [11], pp.15); it is also a particular case of
Lemma 3.3, pp.80, in Ladyzhenskaya [10]: (obtained by taking l = 1 and r = s = 0).
Lemma 2.4. Let Ω be a domain of IRn with boundary ∂Ω satisfying the cone
property. Then, the functional space W 2,1p (Q) is continuously embedded in u ∈
Lq(Q) for q satisfying: (i) 1 ≤ q ≤ p(n+2)n+2−2p , if p < n+22 ; (ii) 1 ≤ q < ∞, if
p = n+22 and (iii) q = ∞, if p > n+22 . In particular, for such q and any function
u ∈W 2,1p (Q) we have that
‖u‖Lq(Q) ≤ C‖u‖W 2,1p (Q),
with a constant C depending only on Ω, T , p, q, n.
In the cases (ii), (iii) or in (i) when 1 ≤ q < p(n+ 2)
n+ 2− 2p , the referred embedding
is compact.
Next, we consider the following simple parabolic initial-boundary value problem:
(2.1)

∂u
∂t
−
n∑
i,j=1
aij(x, t)
∂u2
∂xixj
+
n∑
j=1
ai(x, t)
∂u
∂xj
+ a(x, t)u = f in Q,
n∑
i=1
bi(x, t)
∂u
∂xi
+ b(x, t)u = 0 on Γ,
u(·, 0) = u0(·) in Ω.
Existence and uniqueness of solutions for this problem is a particular case of
Theorem 9.1, pp.341, in Ladyzenskaya [10] for the case of Neumann boundary
condition, according to the remarks at the end Chapter IV, section 9, p. 351 in
[10]. In the following, we state this particular result, stressing the dependencies
certain norms of the coefficients, that will be important in our future arguments.
Proposition 2.5. Let Ω be a bounded domain in Rn, with a C2 boundary ∂Ω, aij
be bounded continuous functions in Q, and q > 1. Assume that
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(1) aij ∈ C(Q¯), i, j = 1, . . . , n; [aij ]n×n is a real positive matrix such that for
some positive constant β we have
n∑
i,j=1
aij(x, t)ξiξj ≥ β|ξ|2 for all (x, t) ∈ Q
and all ξ ∈ Rn, ;
(2) f ∈ Lp(Q);
(3) ai ∈ Lr(Q) with either r = max
(
p, n+ 2
)
if p 6= n+ 2 or r = n+ 2 + ε, for
any ε > 0, if p = n+ 2;
(4) a ∈ Ls(Q) with either s = max (p, (n + 2)/2) if p 6= (n + 2)/2 or s =
(n+ 2)/2 + ε, for any ε > 0, if p = (n+ 2)/2.
(5) bi, b ∈ C2(Γ¯), i = 1, . . . , n, and the coefficients bi(x, t) satisfy the condition∣∣∣∣ n∑
i=1
bi(x, t)ηi(x)
∣∣∣∣ ≥ δ > 0 for a.e. in ∂Ω × (0, T ), where ηi(x) is the ith-
component of the unitary outer normal vector to ∂Ω in x ∈ ∂Ω;
(6) u0 ∈ W 2−
2
p
p (Ω) with p 6= 3 and satisfying the compatibility condition
n∑
i=1
bi
∂u0
∂xi
+ b u0 = 0 on ∂Ω when p > 3.
Then, there exists a unique solution u ∈W 2,1p (Q) of Problem (2.1); moreover, there
is a positive constant Cp such that the solution satisfies
(2.2) ‖u‖W 2,1p (Q) ≤ Cp
(
‖f‖Lp(Q) + ‖u0‖
W
2− 2
p
p (Ω)
)
.
Such constant Cp depends only on Ω, T , p, r, s, β, δ and on the norms ‖bi‖C2(Γ¯),
‖b‖C2(Γ¯), ‖aij‖C(Q¯), ‖ai‖Lr(Q) and ‖a‖Ls(Q). Moreover, we may assume that the
dependencies of Cp on stated the norms are non decreasing.
Remark 2.6. The result set out in Proposition 2.5 can be formulated for the
parabolic problem with Dirichlet conditions (see Ladyzenskaya [10, Theorem 9.1,
pp.341]). In the problem with Dirichlet condition the compatibility condition in
Proposition 2.5-(6) can be replaced by u0 = 0 on ∂Ω when p > 3/2. This way, all
the results in this paper holds if we replaced the Neumann conditions by Dirichlet
conditions.
3. An auxiliary problem
In this section we will prove an auxiliary result to be used in the proof of The-
orem 2.2. To cope with difficulties with the signs of certain terms during the
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derivation of the estimates, we firstly have to consider the following modified prob-
lem:
(3.1)

∂Nˆ
∂t
= rN − µN Nˆ − β1NˆAˆ− αNγN |Dˆ|Nˆ , in Q,
∂Aˆ
∂t
= rAAˆ
(
1− Aˆ
kA
)
− (µA + A)Aˆ− αAγA|Dˆ|Aˆ, in Q,
∂Dˆ
∂t
= σ∆Dˆ + µχω − γDˆAˆ− γN DˆNˆ − τDˆ, in Q,
∂Dˆ
∂η
(·) = 0, on Γ,
Nˆ(·, 0) = N0(·), Aˆ(·, 0) = A0(·), Dˆ(·, 0) = D0(·), in Ω.
Now we observe that, since the equation for Nˆ in this last problem is, for each
x ∈ Ω, an ordinary differential equation which is linear in Nˆ , we can find an
explicit expression for it in terms of Aˆ and |Dˆ|. However, Aˆ is, for each x ∈ Ω, a
nonlinear differential equation in Aˆ, and we can determine its explicit expression
in terms of |Dˆ| using Bernoulli’s method. Using these observations and setting
λ = rA−(µA+A), we introduce operators Λ : L∞(Q)→ L∞(Q) and Θ : L∞(Q)→
L∞(Q), defined respectively by
(3.2) Λ(φ)(x, t) =
A0(x)kAe
λte−αAγA
∫ t
0
|φ(ξ,x)|dξ
kA +A0(x)rA
∫ t
0
eλse−αAγA
∫ s
0
|φ(ξ,x)|dξds
and
(3.3) Θ(φ)(x, t) =
N0(x) + rN
∫ t
0
eµNseαNγN
∫ s
0
|φ(x,ξ)|dξeβ1
∫ s
0
Λ(φ)(x,ξ)dξds
eµN teαNγN
∫ t
0
|φ(x,ξ)|dξeβ1
∫ t
0
Λ(φ)(x,ξ)dξ
,
where 0 ≤ s ≤ t ≤ T .
Remark 3.1. Thus, (Nˆ , Aˆ, Dˆ) is a solution of (3.1) if, and only if, Nˆ = Θ(Dˆ),
Aˆ = Λ(Dˆ) and Dˆ satisfies the following integro-differential system:
(3.4)

∂Dˆ
∂t
= σ∆Dˆ + µχω − γDˆΛ(Dˆ)− γN DˆΘ(Dˆ)− τDˆ, in Q,
∂Dˆ
∂η
(·) = 0, on Γ,
Dˆ(·, 0) = D0(·), in Ω.
Remark 3.2. Notice that, to guarantee that (N,A,D), with D = Dˆ, N = Θ(Dˆ)
and A = Λ(Dˆ) is also a solution of system (1.1), it is enough to prove that the
solution Dˆ of Problem (3.4) is nonnegative.
For the Problem 3.4, we have the following existence result:
Proposition 3.3. Assuming that the Technical Hypotheses 2.1 hold, there exists
at least one nonnegative solution Dˆ ∈W 2,14 (Q) of Problem (3.4). Moreover, Dˆ ≤ µτ
a.e. in Q and
||Dˆ||W 2,14 (Q) ≤ C,
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where C is a constant depending on µ, T , ω and ||D0||
W
3
2
4 (Ω)
.
Lemma 3.4. Let f : (0, T )→ R differentiable such that f(t) > 0 and f ′(t) ≥ 0. If
g(t) =
∫ t
0
f(x)dx
f(t) , then g(t) ≤ T , for all t ∈ (0, T ).
Proof: Since f is continuous in (0, T ), it follows that
g′(t) =
f(t)2 − f ′(t) ∫ t
0
f(x)dx
f(t)2
= 1− f
′(t)
f(t)
g(t).
As f(t) > 0 we have g(t) ≥ 0 and using the fact that f ′(t) ≥ 0 we obtain
f ′(t)
f(t) g(t) ≥ 0. Therefore, g′(t) ≤ 1, which suggests g(t) ≤ t, for all t ∈ (0, T ). Thus,
g(t) ≤ T , as intended. 
Since in the proof of existence of solutions of (3.4) the expression of Λ and Θ
will play important roles, we state some of their properties in the following:
Lemma 3.5. If N0, A0 ∈ L∞(Ω) and Cλ = max{1, eλT }, then for any φ, φ1, φ2 ∈
L∞(Q) and for almost every (x, t) ∈ Q, there holds
(i) 0 ≤ Θ(φ)(x, t) ≤ ||N0||L∞(Ω) + rNT ;
(ii) 0 ≤ Λ(φ)(x, t) ≤ Cλ||A0||L∞(Ω);
(iii) ‖Λ(φ1)− Λ(φ2)‖L∞(Q) ≤ C1‖φ1 − φ2‖L∞(Q),
where C1 is a constant depending on rA, kA, αA, γA, Cλ, T and ||A0||L∞(Ω);
(iv) ‖Θ(φ1)−Θ(φ2)‖L∞(Q) ≤ C2‖φ1 − φ2‖L∞(Q),
where C2 is a constant depending on rN , µN , β1, αN , γN , Cλ, C1, T,
||φ1||L∞(Q), ||φ2||L∞(Q), ||N0||L∞(Ω) and ||A0||L∞(Ω).
Proof (i) and (ii): By the expressions (3.2) and (3.3) it is immediate that
Λ(φ)(x, t),Θ(φ)(x, t) ≥ 0. To prove that Θ(φ)(x, t) ≤ ||N0||L∞(Ω)+rNT , we observe
that
Θ(φ)(x, t) =
N0(x) + rN
∫ t
0
eµNseαNγN
∫ s
0
|φ(x,ξ)|dξeβ1
∫ s
0
Λ(φ)(x,ξ)dξds
eµN teαNγN
∫ t
0
|φ(x,ξ)|dξeβ1
∫ t
0
Λ(φ)(x,ξ)dξ
≤ N0(x) + rN
∫ t
0
eµNseαNγN
∫ s
0 |φ(x,ξ)|dξeβ1
∫ s
0 Λ(φ)(x,ξ)dξds
eµNteαNγN
∫ t
0 |φ(x,ξ)|dξeβ1
∫ t
0 Λ(φ)(x,ξ)dξ
.
Fixed x ∈ Ω, we define
g(x, t) =
∫ t
0
eµNseαNγN
∫ s
0
|φ(x,ξ)|dξeβ1
∫ s
0
Λ(φ)(x,ξ)dξds
eµN teαNγN
∫ t
0
|φ(x,ξ)|dξeβ1
∫ t
0
Λ(φ)(x,ξ)dξ
,
and using the Lemma 3.4 with f(x, t) = eµN teαNγN
∫ t
0
|φ(x,ξ)|dξeβ1
∫ t
0
Λ(φ)(x,ξ)dξ, it
follows that
Θ(φ, ϕ)(x, t) ≤ N0(x) + rNT
≤ ||N0||L∞(Ω) + rNT.
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To prove that Λ(φ)(x, t) ≤ Cλ||A0||L∞(Ω), note that
Λ(φ)(x, t) =
A0(x)kAe
λte−αAγA
∫ t
0
|φ(ξ,x)|dξ
kA +A0(x)rA
∫ t
0
eλse−αAγA
∫ s
0
|φ(ξ,x)|dξds
≤ 1kAA0(x)kAeλte−αAγA
∫ t
0
|φ(x,ξ)|dξ
≤ A0(x)eλt ≤ CλA0(x) ≤ Cλ||A0||L∞(Ω).
Proof (iii): We firstly need to observe that, due to the mean value inequality,
given any z1, z2 ∈ IR, there is θ = θ(z1, z2) such that ez2−ez1 = e(1−θ)z1+θz2(z2−z1);
in particular, for any z1, z2 ≤ 0 we also have (1− θ)z1 + θz2 ≤ 0 and thus
(3.5) |ez2 − ez1 | ≤ |z2 − z1|, ∀z1, z2 ≤ 0.
Secondly, we note that by the inequality (3.5) and by φi ∈ L∞(Q), i = 1, 2, we
obtain
(3.6)∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ − e−αAγA ∫ t0 |φ2(x,ξ)|dξ∣∣ ≤ ∣∣− αAγA ∫ t0 (|φ1(x, ξ)| − |φ2(x, ξ)|)dξ∣∣
≤ αAγAT ||φ1 − φ2||L∞(Q).
Thirdly, we observe that
∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ ∫ t
0
eλse−αAγA
∫ s
0
|φ2(x,ξ)|dξds −
e−αAγA
∫ t
0
|φ2(x,ξ)|dξ
∫ t
0
eλse−αAγA
∫ s
0
|φ2(x,ξ)|dξds
∣∣ ≤
∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ − e−αAγA ∫ t0 |φ2(x,ξ)|dξ∣∣ ∫ t
0
eλse−αAγA
∫ s
0
|φ2(x,ξ)|dξds +
e−αAγA
∫ t
0
|φ2(x,ξ)|dξ
∫ t
0
eλs
∣∣e−αAγA ∫ s0 |φ1(x,ξ)|dξ − e−αAγA ∫ s0 |φ2(x,ξ)|dξ∣∣ds.
How eλT ≤ Cλ and e−αAγA||φ2||L∞(Q) ≤ 1, and using study analogous to that
done in (3.6), we obtain that
(3.7)
∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ ∫ t
0
eλse−αAγA
∫ s
0
|φ2(x,ξ)|dξds −
e−αAγA
∫ t
0
|φ2(x,ξ)|dξ
∫ t
0
eλse−αAγA
∫ s
0
|φ1(x,ξ)|dξds
∣∣ ≤
2αAγACλT
2||φ1 − φ2||L∞(Q).
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Finally, the expression in (3.3) suggests
|Λ(φ1)(x, t)− Λ(φ2)(x, t)| ≤
A0(x)e
λt
∣∣∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ − e−αAγA ∫ t0 |φ2(x,ξ)|dξ∣∣∣∣ +
1
kA
A0(x)
2
rAe
λt
∣∣∣∣e−αAγA ∫ t0 |φ1(x,ξ)|dξ ∫ t
0
eλse−αAγA
∫ s
0
|φ2(x,ξ)|dξds −
e−αAγA
∫ t
0
|φ2(x,ξ)|dξ
∫ t
0
eλse−αAγA
∫ s
0
|φ1(x,ξ)|dξds
∣∣∣∣,
and using the estimates obtained in (3.6) and (3.7) and making the possible sim-
plifications, we obtain
|Λ(φ1)(x, t)− Λ(φ2)(x, t)| ≤
||A0||L∞(Ω)CλαAγAT ||φ1 − φ2||L∞(Q) +
2
kA
||A0||2L∞(Ω)rACλ2αAγAT 2||φ1 − φ2||L∞(Q),
for almost everything (x, t) ∈ Q, i.e.,
(3.8) ||Λ(φ1)− Λ(φ2)||L∞(Q) ≤ C1 ||φ1 − φ2||L∞(Q).
Proof (iv): First, note that
∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ − eαNγN ∫ t0 |φ1(x,ξ)|dξeβ1 ∫ t0 Λ(φ1)(x,ξ)dξ∣∣ ≤
eαNγN
∫ t
0
|φ2(x,ξ)|dξ∣∣eβ1 ∫ t0 Λ(φ2)(x,ξ)dξ − eβ1 ∫ t0 Λ(φ1)(x,ξ)dξ∣∣ +
eβ1
∫ t
0
Λ(φ1)(x,ξ)dξ
∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξ − eαNγN ∫ t0 |φ1(x,ξ)|dξ∣∣,
and by the inequality (3.5) and by Λ(φi), φi ∈ L∞(Q), i = 1, 2, we obtain
(3.9)∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ − eαNγN ∫ t0 |φ1(x,ξ)|dξeβ1 ∫ t0 Λ(φ1)(x,ξ)dξ∣∣ ≤
eαNγN
∫ t
0
|φ2(x,ξ)|dξβ1T ||Λ(φ1)− Λ(φ2)||L∞(Q) +
eβ1
∫ t
0
Λ(φ1)(x,ξ)dξαNγNT ||φ1 − φ2||L∞(Q).
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Since
∣∣∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ ∫ t
0
eµNseαNγN
∫ s
0
|φ1(x,ξ)|dξeβ1
∫ s
0
Λ(φ1)(x,ξ)dξds −
eαNγN
∫ t
0
|φ1(x,ξ)|dξeβ1
∫ t
0
Λ(φ1)(x,ξ)dξ
∫ t
0
eµNseαNγN
∫ s
0
|φ2(x,ξ)|dξeβ1
∫ s
0
Λ(φ2)(x,ξ)dξds
∣∣∣∣ ≤
eαNγN
∫ t
0
|φ2(x,ξ)|dξeβ1
∫ t
0
Λ(φ2)(x,ξ)dξ ×
∫ t
0
eµNs
∣∣∣∣eαNγN ∫ s0 |φ1(x,ξ)|dξeβ1 ∫ s0 Λ(φ1)(x,ξ)dξ − eαNγN ∫ s0 |φ2(x,ξ)|dξeβ1 ∫ s0 Λ(φ2)(x,ξ)dξ∣∣∣∣ds +∣∣∣∣eαNγN ∫ s0 |φ2(x,ξ)|dξeβ1 ∫ s0 Λ(φ2)(x,ξ)dξ − eαNγN ∫ s0 |φ1(x,ξ)|dξeβ1 ∫ s0 Λ(φ1)(x,ξ)dξ∣∣∣∣ ×∫ t
0
eµNseαNγN
∫ s
0
|φ2(x,ξ)|dξeβ1
∫ s
0
Λ(φ2(x,ξ)dξ,
doing ||φ||L∞(Q) = max{||φ1||L∞(Q), ||φ2||L∞(Q)} and study analogous to that done
in (3.9), guarantees us
(3.10)∣∣∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ ∫ t
0
eµNseαNγN
∫ s
0
|φ1(x,ξ)|dξeβ1
∫ s
0
Λ(φ1)(x,ξ)dξds −
eαNγN
∫ t
0
|φ1(x,ξ)|dξeβ1
∫ t
0
Λ(φ1)(x,ξ)dξ
∫ t
0
eµNseαNγN
∫ s
0
|φ2(x,ξ)|dξeβ1
∫ s
0
Λ(φ2)(x,ξ)dξds
∣∣∣∣ ≤
eαNγN
∫ t
0
|φ2(x,ξ)|dξeβ1
∫ t
0
Λ(φ2)(x,ξ)dξeµT eαNγNT ||φ||L∞(Q)β1T 2 ×
||Λ(φ1)− Λ(φ2)||L∞(Q) +
eαNγN
∫ t
0
|φ2(x,ξ)|dξeβ1
∫ t
0
Λ(φ2)(x,t)dξeµT eβ1TCλ||A0||L∞(Ω)αNγNT 2 ×
||φ1 − φ2||L∞(Q) +
eαNγN
∫ t
0
|φ2(x,ξ)|dξβ1T 2||Λ(φ1)− Λ(φ2)||L∞(Q) ×
eµNT eαNγNT ||φ||L∞(Q)eβ1TCλ||A0||L∞(Ω) +
eβ1
∫ t
0
Λ(φ1)(x,ξ)dξαNγNT
2||φ1 − φ2||L∞(Q) ×
eµNT eαNγNT ||φ||L∞(Q)eβ1TCλ||A0||L∞(Ω) .
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Finally, the expression in (3.3) suggests
|Θ(φ1)(x, t)−Θ(φ2)(x, t)| ≤
1
eαNγN
∫ t
0
|φ1(x,ξ)|dξeβ1
∫ t
0
Λ(φ1)(x,ξ)dξeαNγN
∫ t
0
|φ2(x,ξ)|dξeβ1
∫ t
0
Λ(φ2)(x,ξ)dξ
×(
N0(x)
∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ − eαNγN ∫ t0 |φ1(x,ξ)|dξeβ1 ∫ t0 Λ(φ1)(x,ξ)dξ∣∣ +
rN
∣∣∣∣eαNγN ∫ t0 |φ2(x,ξ)|dξeβ1 ∫ t0 Λ(φ2)(x,ξ)dξ ∫ t
0
eµNseαNγN
∫ s
0
|φ1(x,ξ)|dξeβ1
∫ s
0
Λ(φ1)(x,ξ)dξds −
eαNγN
∫ t
0
|φ1(x,ξ)|dξeβ1
∫ t
0
Λ(φ1)(x,ξ)dξ
∫ t
0
eµNseαNγN
∫ s
0
|φ2(x,ξ)|dξeβ1
∫ s
0
Λ(φ2)(x,ξ)dξ
∣∣∣∣).
and using the estimates obtained in (3.8), (3.9) and (3.10) and making the possible
simplifications, we obtain
|Θ(φ1)(x, t)−Θ(φ2)(x, t)| ≤
||N0||L∞(Ω)eαNγNT ||φ||L∞(Q)β1T 2C1||φ1 − φ2||L∞(Q) +
||N0||L∞(Ω)eβ1TCλ||A0||L∞(Ω)αNγNT 2||φ1 − φ2||L∞(Q) +
rNe
µNT eαNγNT ||φ||L∞(Q)eβ1TCλ||A0||L∞(Ω)β1T 2C1||φ1 − φ2||L∞(Q) +
rNe
µNT eαNγNT ||φ||L∞(Q)eβ1TCλ||A0||L∞(Ω)αNγNT 2||φ1 − φ2||L∞(Q)
for almost everything (x, t) ∈ Q, i.e.,
||Θ(φ1)−Θ(φ2)||L∞(Q) ≤ C2||φ1 − φ2||L∞(Q).

3.1. Proof of Proposition 3.3. To not overburden the notation, in this subsection
we denote D as a generic solution of the equations that follows.
To get a solution of problem (3.4), we will apply the Leray-Schauder fixed point
theorem to the mapping Ψ defined as follows:
(3.11)
Ψ : [0, 1]× L∞(Q) → L∞(Q)
(l, φ) 7→ D,
where D is the unique solution of
(3.12)

∂D
∂t
= σ∆D + µχω − lγDΛ(φ)− lγNDΘ(φ)− τD, in Q,
∂D
∂η
(·) = 0, on Γ,
D(·, 0) = D0(·), in Ω,
with Λ(φ) and Θ(φ) given by (3.2) and (3.3), respectively.
To apply such theorem we present next a sequence of lemmas:
Lemma 3.6. Suppose N0, A0 ∈ L∞(Ω) and D0 ∈ W
3
2
4 (Ω). Then the mapping
Ψ : [0, 1]× L∞(Q)→ L∞(Q) is well defined.
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Proof: We affirm that the coefficients of the Problem 3.12 satisfy the hypotheses
of the Proposition 2.5. For example, it is immediate that −lγΛ(φ)− lγNΘ(φ)− τ ∈
L4(Q), because by Lemma 3.5, Λ(φ),Θ(φ) ∈ L∞(Q). Thus, we conclude that
there is a unique solution D ∈W 2,14 (Q) of problem 3.12. Moreover, D satisfies the
following estimate:
(3.13)
||D||W 2,14 (Q) ≤ Cp
(
||µχω||L4(Q) + ||D0||
W
3
2
4 (Ω)
)
≤ Cp
(
µ|ω| 14T 14 + ||D0||
W
3
2
4 (Ω)
)
.
Finally, from Lemma 2.4, we have W 2,14 (Q) ↪→ L∞(Q), and we conclude that
the operator Ψ in well defined. 
Lemma 3.7. Suppose D is a solution of (3.12) and 0 ≤ D0 ≤ µτ a.e. in Ω, then
0 ≤ D ≤ µτ a.e. in Q.
Proof: Multiplying the first equation in (3.12) by D− and integrating into Ω, we
get
1
2
d
dt
∫
Ω
(D−)2 dx = −σ
∫
Ω
|∇D−|2 dx− µ
∫
ω
D− dx
−lγ
∫
Ω
Λ(φ)(D−)2 dx− lγN
∫
Ω
Θ(φ)(D−)2 dx− τ
∫
Ω
(D−)2 dx.
Thus,
d
dt
∫
Ω
(D−)2dx ≤ 0,
and using Gronwall’s inequality and the fact that D0 ≥ 0 a.e. in Ω, we obtain∫
Ω
(D−)2dx ≤
∫
Ω
(D0
−)2dx = 0,
that is, ||D−(·, t)||L2(Ω) = 0 for all t ∈ (0, T ), where we conclude that D− = 0 a.e.
in Q and therefore D ≥ 0 a.e. in Q.
Now, we observe that the first equation in (3.12) can be rewritten as
∂
∂t
(
D − µ
τ
)
= σ∆
(
D − µ
τ
)− lγΛ(φ)D − lγNΘ(φ)D − τ(D − µχω
τ
)
.
Multiplying by (D − µτ )+ and integrating in Ω, we obtain
1
2
d
dt
∫
Ω
((
D − µ
τ
)+)2
dx = −σ
∫
Ω
∣∣∇(D − µ
τ
)+∣∣2 dx
−lγ
∫
Ω
Λ(φ)D
(
D − µ
τ
)+
dx− lγN
∫
Ω
Θ(φ)D
(
D − µ
τ
)+
dx
−τ
∫
ω
((
D − µ
τ
)+)2
dx− τ
∫
Ω\ω
D
(
D − µ
τ
)+
dx,
that is,
d
dt
∫
Ω
((
D − µ
τ
)+)2
dx ≤ 0.
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Thus, using Gronwall’s inequality and the fact that D0 ≤ µτ a.e. in Ω, it follows
that ∫
Ω
((
D − µ
τ
)+)2
dx ≤
∫
Ω
((
D0 − µ
τ
)+)2
dx = 0,
that is, ||(D(·, t) − µτ )+||L2(Ω) = 0 for all t ∈ (0, T ), and therefore (D − µτ )+ = 0
a.e. in Q, and we conclude that D ≤ µτ a.e. in Q.

Lemma 3.8. For each fixed l ∈ [0, 1], the mapping Ψ(l, ·) : L∞(Q) → L∞(Q) is
compact, i.e., it is continuous and maps bounded sets into relatively compacts sets.
Proof: The functions Ψ(l, φ1) = D1 and Ψ(l, φ2) = D2 satisfy the system
∂Di
∂t
= σ∆Di + µχω − lγDiΛ(φ1)− lγNDiΘ(φi)− τDi, in Q,
∂Di
∂η
(·) = 0, on Γ,
Di(·, 0) = D0(·), in Ω,
with i = 1, 2; letting D˜ = D1 −D2, we have
(3.14)

∂D˜
∂t
− σ∆D˜ + lγD˜Λ(φ2) + lγN D˜Θ(φ2) + τD˜ =
−lγD1(Λ(φ1)− Λ(φ2))− lγND1(Θ(φ1)−Θ(φ2)), in Q,
∂D˜
∂η
(·) = 0, on Γ,
D˜(·, 0) = D˜0(·) = 0, in Ω.
Using the Proposition 2.5 and the fact that L∞(Q) ↪→ L4(Q) and D1 ≤ µτ , we
get
||D˜||W 2,14 (Q) ≤ Cp|| − lγD1(Λ(φ1)− Λ(φ2))− lγND1(Θ(D1)−Θ(D2))||L4(Q)
≤ C¯p|| − lγD1(Λ(φ1)− Λ(φ2))− lγND1(Θ(φ1)−Θ(φ2))||L∞(Q)
≤ C¯pγ µ
τ
||Λ(φ1)− Λ(φ2)||L∞(Q) + C¯pγN µ
τ
||Θ(φ1)−Θ(φ2)||L∞(Q).
Then, by Lemmas 3.5 and 2.4, we finally have
||Ψ(l, φ1)−Ψ(l, φ2)||L∞(Q) ≤ C||φ1 − φ2||L∞(Q),
where C depends on C¯p, C1, C2, γ, γN , µ, τ and the immersion constant.
To show that Ψ(l, ·) is compact, we use the fact that the immersion W 2,14 (Q) ↪→
L∞(Q) is compact and that Ψ(l, ·) is the composition between the inclusion oper-
ator and the solution operator, i.e., Ψ(l, ·) : L∞(Q)→W 2,14 (Q)→ L∞(Q). 
Lemma 3.9. Given a bounded subset B ⊂ L∞(Q), for each φ ∈ B, the mapping
Ψ(·, φ) : [0, 1]→ L∞(Q) is uniformly continuous with respect to B.
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Proof: Since B ∈ L∞(Q) is bounded, there is rB ≥ 0 such that, for any φ ∈ B,
we have ||φ||L∞(Q) ≤ rB . Now, let us fix φ ∈ L∞(Q) and consider l1, l2 ∈ [0, 1] and
denote Ψ(l1, φ) = D1, Ψ(l2, φ) = D2 and D˜ = D1 −D2. Then, D˜ satisfies
(3.15)

∂D˜
∂t
− σ∆D˜ + γl2Λ(φ)D˜ + γN l2Θ(φ)D˜ + τD˜ =
γΛ(φ)D1(l1 − l2)− γNΘ(φ)D1(l1 − l2), in Q,
∂D˜
∂η
= 0, on Γ,
D˜(·, 0) = D˜0(·) = 0, in Ω.
Using the Proposition 2.5 and the fact that L∞(Q) ↪→ L4(Q), D1 ≤ µτ , we get
||D˜||W 2,14 (Q) ≤ Cp||γΛ(φ)D1(l1 − l2)− γNΘ(φ)D1(l1 − l2)||L4(Q)
≤ C¯pγ µ
τ
|l1 − l2|||Λ(φ)||L∞(Q) + C¯pγN µ
τ
|l1 − l2|||Θ(φ)||L∞(Q).
Then, by Lemmas 3.5 and 2.4, we finally have
||Ψ(l1, φ)−Ψ(l2, φ)||L∞(Q) ≤ C|l1 − l2|,
where C depends on C¯p, γ, γN , µ, τ , rN , T , Cλ, ||N0||L∞(Ω), ||A0||L∞(Ω) and the
immersion constant. 
Lemma 3.10. Suppose D0 ≤ µτ a.e. in Ω, then there exists a number ρ > 0 such
that, for any l ∈ [0, 1] and any possible fixed point D ∈ L∞(Q) of Ψ(l, ·), there holds
‖D‖L∞(Q) < ρ.
Proof: Let D ∈ L∞(Q) such that Ψ(l,D) = D. The analogous demonstra-
tion made in Proposition 3.7 guarantees us ||D||L∞(Q) ≤ µτ . Therefore, just take
ρ = µτ + 1. 
Lemma 3.11. The mapping Ψ(0, ·) : L∞(Q)→ L∞(Q) has a unique fixed point.
Proof: Indeed, letting l = 0 in 3.12, D is a fixed point of Ψ(0, ·) if, and only if, D
is the unique solution to the problem
∂D
∂t
= σ∆D + µχω − τD, in Q,
∂D
∂η
(·) = 0, on Γ,
D(·, 0) = D0(·), in Ω.
But Proposition 2.5 guarantees the existence of a unique solutionD ∈W 2,14 (Q) ↪→
L∞(Q) of this last problem; therefore Ψ(0, ·) has a unique fixed point in L∞(Q). 
Proposition 3.12. There is a nonnegative solution Dˆ ∈ W 2,14 (Q) of the problem
(3.4).
Proof: From Lemmas 3.6, 3.8, 3.9, 3.10 and 3.11, we conclude that the mapping
Ψ : [0, 1] × L∞(Q) → L∞(Q) satisfies the hypotheses of the Leray-Schauder’s
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fixed point theorem (see Friedman [8, pp. 189, Theorem 3]). Thus, there ex-
ists Dˆ ∈ L∞(Q) such that Ψ(1, Dˆ) = Dˆ. Moreover, by Lemmas 3.6 and 3.7,
Dˆ ∈W 2,14 (Q) is nonnegative and Dˆ is the required solution of (3.4). 
4. Proof of Theorem 2.2
Proposition 4.1. There is a nonnegative solution (Nˆ , Aˆ, Dˆ) ∈ L∞(Q)×L∞(Q)×
W 2,14 (Q) of the modified problem (3.1).
Proof: Just combine the Proposition 3.12, the Remark 3.1 and the Lemma 3.5. 
Remark 4.2. We affirm that Nˆ , Aˆ ∈ W . Indeed, by Lemma 3.5 we know that
Nˆ = Θ(Dˆ), Aˆ = Λ(Dˆ) ∈ L∞(Q). Moreover, returning to the first equation of (3.1),
using the Lemmas 3.5 and 3.7, it follows that:
(4.1)∣∣∣∣∂Nˆ∂t
∣∣∣∣ ≤ rN + µN (||N0||L∞(Ω) + rNT ) + β1(||N0||L∞(Ω) + rNT )Cλ||A0||L∞(Ω)
+αNγN
µ
τ
(||N0||L∞(Ω) + rNT ),
a.e. in Q, i.e., Nˆt ∈ L∞(Q).
Moreover, returning to the second equation of (3.1) and using, again, the Lemmas
3.5 and 3.7, we get:
(4.2)∣∣∣∣∂Aˆ∂t
∣∣∣∣ ≤ rACλ||A0||L∞(Ω) + rAkA (Cλ||A0||L∞(Ω))2 + (µA + A)Cλ||A0||L∞(Ω)
+αAγA
µ
τ
Cλ||A0||L∞(Ω),
a.e. in Q, i.e., Aˆt ∈ L∞(Q).
Proposition 4.3. There is a nonnegative solution (N,A,D) ∈W ×W ×W 2,14 (Q)
of problem (1.1).
Proof: Just combine the Proposition 4.1 and the Remarks 3.2 and 4.2. 
Proposition 4.4. The solution (N,A,D) of the problem (1.1) is unique.
Proof: Let (N1, A1, D1) and (N2, A2, D2) be solutions to the problem (1.1); if
N˜ = N1 − N2, A˜ = A1 − A2 and D˜ = D1 − D2, then N˜ , A˜ and H˜ satisfy the
following problems, respectively:
(4.3)
∂N˜
∂t
= −µN N˜ − β1A1N˜ − β1N2A˜− αNγNN1D˜ − αNγND2N˜ , in Q,
N˜(·, 0) = N˜0(·) = 0, in Ω,
(4.4)
∂A˜
∂t
= rAA˜− rA
kA
(A1 +A2)A˜− (µA + A)A˜− αAγAA1D˜ − αAγAD2A˜, in Q,
A˜(·, 0) = A˜0(·) = 0, in Ω,
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(4.5)

∂D˜
∂t
= σ∆D˜ − γA1D˜ − γD2A˜− γNN1D˜ − γND2N˜ − τD˜, in Q,
∂D˜
∂η
(·) = 0, on Γ,
D˜(·, 0) = D˜0(·) = 0, in Ω.
Multiplying the first equation of (4.3) by N˜ , integrating into Ω, using the fact
that N1 ≤ ||N0||L∞(Ω) + rNT and the inequality of Young, we have
1
2
d
dt
∫
Ω
N˜2dx = −µN
∫
Ω
N˜2dx− β1
∫
Ω
N2A˜N˜dx− αNγN
∫
Ω
N1D˜N˜dx
− αNγN
∫
Ω
D2N˜
2dx
≤ (||N0||L∞(Ω) + rNT )
(
β1
∫
Ω
|A˜||N˜ |dx+ αNγN
∫
Ω
|D˜||N˜ |dx
)
≤ C
∫
Ω
(A˜2 + N˜2 + H˜2)dx,
where C depends on β1, αN , γN , rN , T and ||N0||L∞(Ω).
Now, multiplying the first equation of (4.4) by A˜, integrating into Ω, using the
fact that A1 ≤ Cλ||A0||L∞(Ω) and the inequality of Young, we obtain
1
2
d
dt
∫
Ω
A˜2dx = rA
∫
Ω
A˜2dx− rA
kA
∫
Ω
(A1 +A2)A˜
2dx− (µA + A)
∫
Ω
A˜2dx
− αAγA
∫
Ω
A1D˜A˜dx− αAγA
∫
Ω
D2A˜
2dx
≤ rA
∫
Ω
|A˜|2dx+ αAγACλ||A0||L∞(Ω)
∫
Ω
|D˜||A˜|dx
≤ C
∫
Ω
(A˜2 + N˜2 + H˜2)dx,
where C depends on rA, αA, γA Cλ and ||A0||L∞(Ω).
Lastly, multiplying the first equation of (4.5) by H˜, integrating into Ω, using the
fact that D ≤ µτ and the inequality of Young, we obtain
1
2
d
dt
∫
Ω
D˜2dx = −σ
∫
Ω
|∇D˜|2dx− γ
∫
Ω
A1D˜
2dx− γ
∫
Ω
D2A˜D˜dx
− γN
∫
Ω
N1D˜
2dx− γN
∫
Ω
D2N˜D˜dx− τ
∫
Ω
D˜2dx
≤ γ µ
τ
∫
Ω
|A˜||D˜|dx+ γN µ
τ
∫
Ω
|N˜ ||D˜|dx
≤ C
∫
Ω
(A˜2 + N˜2 + H˜2)dx,
where C depends on γ, γN , µ and τ .
A MODEL FOR TUMOR GROWTH AND CHEMOTHERAPY 17
Thus,
d
dt
(∫
Ω
(|N˜ |2 + |A˜|2 + |D˜|2)dx
)
≤ C
∫
Ω
(|N˜ |2 + |A˜|2 + |D˜|2)dx,
and using the Gronwall’s inequality, we finally∫
Ω
(|N˜ |2 + |A˜|2 + |D˜|2)dx ≤ eCT
∫
Ω
(|N˜0|2 + |A˜0|2 + |D˜0|2)dx = 0,
that is, ||N˜(·, t)||2L2(Ω) + ||A˜(·, t)||2L2(Ω) + ||D˜(·, t)||2L2(Ω) = 0, for all t ∈ (0, T ).
Where we conclude N˜ = A˜ = D˜ = 0 a.e. in Q and therefore N1 = N2, A1 = A2
and D1 = D2 a.e. in Q. 
5. Numerical simulations
In this section, we provide numerical simulations illustrating different model
behaviors. The settings and methods used to implement the simulations are the
following. We consider the spatial domain as a square Ω = [0, L] × [0, L], with
L = 1, discretized with n = 50 steps ∆x = ∆y = L/n = 0.02. The Laplacian ∆D
is approximated by second order centered finite differences and the coupled ODE
system arising from such discretization is solved with the method of lines in the
software Mathematica. The simulations run from time t = 0 until t = 25 (which is
enough to achieve stationary behavior in all simulations).
The initial conditions for numerical simulations are N(x, 0) = N2, A(x, 0) = A2,
D(x, 0) = 0, where (N2, A2, 0) is a globally asymptotically stable equilibrium point
for the ODE system (1.2) without treatment (ν = 0). The expressions for N2 and
A2 are:
N2 =
rN
µN + β1A2
, A2 =
rA − µA − A
rA
KA.
Such equilibrium is allways globally asymptotically stable in system (1.2) (see de-
tails in [6]). From the biological point of view, these initial conditions correspond
to the start of chemotherapy application when a tumor is already a formed, where
the normal cells were not able to control tumor growth, and no chemotherapy was
applied until the tumor reached a stationary state.
To avoid large numbers and numerical instabilities, we re-scale the populations
with respect to their possible maximum values, setting N ← N/(rN/µN ) and A←
A/KA. Therefore, the population sizes range from 0 to 1. The re-scaled parameter
values used in the model simulations were fixed to
rN = 1, µN = 1, rA = 1, KA = 1, β1 = 1.5, µA = 0.05, A = 0.05,
τH = 0.9, γN = 0.1, αN = 1, γA = 1.
These values were chosen to describe: normal cells that reach the equilibrium N =
rN/µN = 1 at absence of tumor cells; a tumor with the same carrying capacity of
normal cells (KA = rN/µN = 1) and a greater absorption of the chemotherapeutic
drug by tumor cells in comparison with normal cells (γA > γN ), due to the drug
specificity.
In order to illustrate different biological outcomes in the model simulations, we
allowed the following parameters to assume different values: the chemotherapeutic
drug cytotoxicity against cancer cells αA, the diffusion coefficient of the chemother-
apeutic drug σ and the chemotherapy infusion rate µ. We will show that these
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Simulation Figure Outcome αA µ σ ω
1 1 tumor persistence 5 3 0.1 [0.45, 0.55]× [0.45, 0.55]
2 2 tumor persistence 10 3 0.1 [0, 0.1]
3 3 tumor extinction 10 6 0.1 [0, 0.1]
4 4 tumor extinction 10 3 0.2 [0, 0.1]
5 5 tumor extinction 20 3 0.1 [0, 0.1]
Table 1. Set-up of different simulations an their biological out-
comes. Each row indicates the numerical values used for the
chemotherapeutic parameters αA (cytotoxicity), σ (diffusion coef-
ficient), µ (infusion rate), and the position of ω ⊂ Ω ⊂ R2. Simula-
tion 1 was performed in a two-dimensional domain Ω = [0, 1]×[0, 1],
while simulations 2-5 were performed in a one-dimensional domain
Ω = [0, 1].
properties of the drug and the infusion rate are crucial for determining an effec-
tive treatment. We also simulated different positions for the subset ω, which is
a mathematical description of a blood vessel crossing the tissue, from where the
chemotherapy enters the tissue. The values for parameters αA, σ, µ and the posi-
tion of ω used in each simulation are indicated in Table 1. We present the following
results.
In the first simulation of system (1.1), we confirm that our model and numerical
methods are able to reproduce the expected biological behavior (Figure 1). The
blood vessel crosses the tissue at its center, i.e., ω = [0.45, 0.55] × [0.45, 0.55]. We
use the following parameter values: αA = 5, µ = 3, and σ = 0.1. With such
values, the chemotherapy is not able to lead to tumor extinction. We observe that
tumor cells that are near the blood vessel are eliminated but not extinct by the
chemotherapeutic effect, and those which are distant from the blood vessel persist
(Figure 1).
In order to make easier to illustrate the model dynamics, we present the results
of next simulations in a one-dimensional domain Ω = [0, 1]. In Simulation 2, we
use the same parameters values used in Simulation 1 (see Table 1), but increase
the chemotherapy toxicity αA and move the blood vessel to the left side of the
tissue, ω = [0, 0.1]. Although the tumor cells in the vicinity of the blood vessel
are extinct, the chemotherapy is still not able to eliminate the distant tumor cells
(Figure 2). Thus, we observe tumor persistence in the long-term. In Simulation 3,
we keep the parameters as in Simulation 2, but increase the chemotherapy infusion
rate µ (mimicking a higher dose). We observe that the tumor cells are extinct
in the entire tissue (Figure 3). In Simulation 4, we illustrate other mechanism to
achieve tumor extinction: instead of increasing drug dose, we adopt the parameter
values of Simulation 2, but increase the drug diffusion σ, so that it is capable to
spread over the entire tissue and effectively eliminate all tumor cells (Figure 4).
Finally, in Simulation 5, we also adopt the parameter values of Simulation 2, but
increase the chemotherapy toxicity against tumor cells αA. This also leads to tumor
extinction (Figure 5). An advantage of the strategies adopted in Simulations 4 and
5, in comparison with Simulation 3 (increasing dose), is that the former lead to less
side effects. Simulation 3 describes the use of a drug which spreads faster, while
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Figure 1. Results of Simulation 1, for model (1.1) within a two-
dimensional domain Ω = [0, L] × [0, L] = [0, 1] × [0, 1]. Plots of
model solutions N(x, y, t) (normal cells, blue, top row), A(x, y, t)
(cancer cells, red, middle row) and D(x, y, t) (chemotherapeutic
drug concentration, green, bottom row) at time points t = 0, 1, 15
(columns 1,2 and 3, respectively). See Table 1 for parameter values
used here. At time t = 0, the tumor is spread trough the tissue, and
as chemotherapy is applied (t > 0), the tumor cells are reduced in
the vicinity of the blood vessel, while the distant tumor cells persist
along time (the shape of the solution at time t = 15 is stationary).
Within the vicinity of the blood vessel, the removal of tumor cells
allows the normal tissue to recover and grow.
Simulation 5 illustrates the use of a more potent and specific drug, which targets
more tumor cells but not more normal cells (αN was not changed). Taken together,
these simulations and the different outcomes observed for different parameter values
confirm the ability of the model to consistently describe tumor chemotherapy and
illustrate the potential of mathematical models to provide testable hypothesis that
could be studied together with clinicians in order to achieve better results in the
treatment of cancer.
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Figure 3. Results of Simulation 3, with Ω = [0, L] = [0, 1]. Plots
of model solutions A(x, t) (cancer cells, red), N(x, t) (normal cells,
blue) and D(x, t) (chemotherapeutic drug concentration, green) at
time points t = 0, 3, 6, 9, 12, 15. See Table 1 for parameter values
used here. At time t = 0, the tumor is spread trough the tissue, and
as chemotherapy is applied (t > 0), the tumor cells are reduced and
in the entire tissue. In comparison with Simulation 2, the tumor
extinction is reached because the drug infusion rate µ is increased
here. Within the entire tissue, the removal of tumor cells release
the normal tissue to recover and grow.
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Figure 4. Results of Simulation 4, with Ω = [0, L] = [0, 1]. Plots
of model solutions A(x, t) (cancer cells, red), N(x, t) (normal cells,
blue) and D(x, t) (chemotherapeutic drug concentration, green) at
time points t = 0, 3, 6, 9, 12, 25. See Table 1 for parameter values
used here. At time t = 0, the tumor is spread trough the tissue,
and as chemotherapy is applied (t > 0), the tumor cells are reduced
and in the entire tissue. In comparison with Simulation 2, the
tumor extinction is reached because the drug diffusion coefficient
σ is increased here.
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Figure 5. Results of Simulation 5, with Ω = [0, L] = [0, 1]. Plots
of model solutions A(x, t) (cancer cells, red), N(x, t) (normal cells,
blue) and D(x, t) (chemotherapeutic drug concentration, green) at
time points t = 0, 3, 6, 9, 12, 15. See Table 1 for parameter values
used here. At time t = 0, the tumor is spread trough the tissue, and
as chemotherapy is applied (t > 0), the tumor cells are reduced and
in the entire tissue. In comparison with Simulation 2, the tumor
extinction is reached because the chemotherapy toxicity against
tumor cells, αA, was increased.
